Objectives
Calcaneal quantitative ultrasound (QUS) is a readily accessible and radiation‐free alternative to dual‐energy x‐ray absorptiometry (DXA) for assessing bone mineral density (BMD). Results obtained from QUS measurement cannot directly be compared to DXA, since these techniques capture different bone‐specific parameters. To identify individuals who are likely to have osteoporosis by DXA, device‐specific thresholds have to be defined for QUS. This cross‐sectional study evaluated the accuracy of QUS to identify postmenopausal women with osteoporosis, defined as a T score of –2.5 SDs or lower by DXA, and to calculate device‐specific cutoff values for the QUS device investigated.
Methods
We assessed BMD at the lumbar spine, bilateral femoral neck, and total hip sites with DXA and QUS parameters of the right and left calcanei in a cohort of 245 postmenopausal treatment‐naïve women between 40 and 82 years. Correlation coefficients for BMD and QUS parameters were calculated. Receiver operating characteristic curves were generated, and areas under the curves (AUCs) were evaluated. Cutoff values for QUS were defined.
Results
Calcaneal QUS had the ability to identify postmenopausal women with a T score of –2.5 or lower at the right hip (AUC, 0.887) and left femoral neck (AUC, 0.824). Cutoff values for the QUS T scores at the right (–1.455) and left (–1.480) calcanei were defined for screening purposes.
Conclusions
This study provides insights into the comparative performance of QUS with DXA. Considering the diagnostic accuracy of this modality in comparison to DXA, it can be recommended as a prescreening tool to reduce the number of DXA screenings.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.